Your browser doesn't support javascript.
loading
The discovery of non-basic atrial natriuretic peptide clearance receptor antagonists. Part 1.
Veale, C A; Alford, V C; Aharony, D; Banville, D L; Bialecki, R A; Brown, F J; Damewood, J R; Dantzman, C L; Edwards, P D; Jacobs, R T; Mauger, R C; Murphy, M M; Palmer, W; Pine, K K; Rumsey, W L; Garcia-Davenport, L E; Shaw, A; Steelman, G B; Surian, J M; Vacek, E P.
Afiliación
  • Veale CA; Department of Chemistry, AstraZeneca Pharmaceuticals, Wilmington, DE 19850-5437, USA. chris.veale@astrazeneca.com
Bioorg Med Chem Lett ; 10(17): 1949-52, 2000 Sep 04.
Article en En | MEDLINE | ID: mdl-10987424
ABSTRACT
The cyclic peptide ANP 4-23 and the linear peptide analogue AP-811 have been shown to be selective ANP-CR antagonists. Via alanine scanning and truncation studies we sought to determine which residues in these molecules were important in their binding to the clearance receptor and the relationship between these two molecules. These studies show that several modifications to these compounds are possible which improve physical properties of these molecules while retaining high affinity for the ANP-CR.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factor Natriurético Atrial / Receptores del Factor Natriurético Atrial Idioma: En Revista: Bioorg Med Chem Lett Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2000 Tipo del documento: Article País de afiliación: Estados Unidos
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factor Natriurético Atrial / Receptores del Factor Natriurético Atrial Idioma: En Revista: Bioorg Med Chem Lett Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2000 Tipo del documento: Article País de afiliación: Estados Unidos
...